Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis

Original Article

M.N. Rheault, C.E. Alpers, J. Barratt, S. Bieler, P. Canetta, D.-W. Chae, G. Coppock, U. Diva, L. Gesualdo, H.J. Heerspink, J.K. Inrig, G.M. Kirsztajn, D. Kohan, R. Komers, L.A. Kooienga, K. Lieberman, A. Mercer, I.L. Noronha, V. Perkovic, J. Radhakrishnan, W. Rote, B. Rovin, V. Tesar, H. Trimarchi, J. Tumlin, M.G. Wong, and H. Trachtman

N Engl J Med 2023;389:2436-2445

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
12/27/2023
Course expires: 
12/28/2025

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Please sign in or create an account to take the course.